CHD-associated enhancers shape human cardiomyocyte lineage commitment
Abstract
Enhancers orchestrate gene expression programs that drive multicellular development and lineage commitment. Thus, genetic variants at enhancers are thought to contribute to developmental diseases by altering cell fate commitment. However, while many variant-containing enhancers have been identified, studies to endogenously test the impact of these enhancers on lineage commitment have been lacking. We perform a single-cell CRISPRi screen to assess the endogenous roles of 25 enhancers and putative cardiac target genes implicated in genetic studies of congenital heart defects (CHD). We identify 16 enhancers whose repression leads to deficient differentiation of human cardiomyocytes (CMs). A focused CRISPRi validation screen shows that repression of TBX5 enhancers delays the transcriptional switch from mid- to late-stage CM states. Endogenous genetic deletions of two TBX5 enhancers phenocopy epigenetic perturbations. Together, these results identify critical enhancers of cardiac development and suggest that misregulation of these enhancers could contribute to cardiac defects in human patients.
Data availability
Sequencing data have been deposited in GEO under accession code: GSE190475.
-
CHD-associated enhancers direct human cardiomyocyte lineage commitment.NCBI Gene Expression Omnibus, GSE190475.
Article and author information
Author details
Funding
NIH (DP2GM128203)
- Gary C Hon
Department of Defense (PR172060)
- Nikhil V Munshi
NIH (UM1HG011996)
- Nikhil V Munshi
- Gary C Hon
NIH (1R35GM145235)
- Gary C Hon
CPRIT (RP190451)
- Gary C Hon
NIH (HL136604)
- Nikhil V Munshi
NIH (HL151650)
- Nikhil V Munshi
Burroughs Wellcome Fund (1019804)
- Gary C Hon
Burroughs Wellcome Fund (1009838)
- Nikhil V Munshi
Welch Foundation (I-2103-2022033)
- Gary C Hon
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Benoit Bruneau, University of California, San Francisco, United States
Version history
- Preprint posted: April 10, 2022 (view preprint)
- Received: January 15, 2023
- Accepted: March 10, 2023
- Accepted Manuscript published: April 25, 2023 (version 1)
- Version of Record published: May 3, 2023 (version 2)
Copyright
© 2023, Armendariz et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 948
- Page views
-
- 120
- Downloads
-
- 2
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
- Neuroscience
Transsynaptic viral vectors provide means to gain genetic access to neurons based on synaptic connectivity and are essential tools for the dissection of neural circuit function. Among them, the retrograde monosynaptic ΔG-Rabies has been widely used in neuroscience research. A recently developed engineered version of the ΔG-Rabies, the non-toxic self-inactivating (SiR) virus, allows the long term genetic manipulation of neural circuits. However, the high mutational rate of the rabies virus poses a risk that mutations targeting the key genetic regulatory element in the SiR genome could emerge and revert it to a canonical ΔG-Rabies. Such revertant mutations have recently been identified in a SiR batch. To address the origin, incidence and relevance of these mutations, we investigated the genomic stability of SiR in vitro and in vivo. We found that “revertant” mutations are rare and accumulate only when SiR is extensively amplified in vitro, particularly in suboptimal production cell lines that have insufficient levels of TEV protease activity. Moreover, we confirmed that SiR-CRE, unlike canonical ΔG-Rab-CRE or revertant-SiR-CRE, is non-toxic and that revertant mutations do not emerge in vivo during long-term experiments.
-
- Computational and Systems Biology
- Genetics and Genomics
Quantitative traits are often complex because of the contribution of many loci, with further complexity added by environmental factors. In medical research, systems genetics is a powerful approach for the study of complex traits, as it integrates intermediate phenotypes, such as RNA, protein, and metabolite levels, to understand molecular and physiological phenotypes linking discrete DNA sequence variation to complex clinical and physiological traits. The primary purpose of this review is to describe some of the resources and tools of systems genetics in humans and rodent models, so that researchers in many areas of biology and medicine can make use of the data.